Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit- Proinsulin vaccine

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Mbongue, Jacques C ^a   Nicholas, Dequina A ^a   Zhang, Kangling ^a,b   Kim, Nan Sun ^a,e   Hamilton, Brittany N ^a   Larios, Marco ^a   Zhang, Guangyu ^a   Umezawa, Kazuo ^c   Firek, Anthony F ^d   Langridge, William H R ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Chonbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; MESSENGER RNA; PROINSULIN VACCINE; UNCLASSIFIED DRUG; VACCINE; CHOLERA TOXIN; PROINSULIN; PROTEOME; SUBUNIT VACCINE;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE FUSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IDO1 GENE; IMMUNOBLOTTING; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MONOCYTE; PROTEIN FUNCTION; PROTEOMICS; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; CLUSTER ANALYSIS; CYTOLOGY; GENE EXPRESSION PROFILING; GENETICS; IMMUNOLOGY; METABOLISM;

CELL DIFFERENTIATION; CHOLERA TOXIN; CLUSTER ANALYSIS; DENDRITIC CELLS; GENE EXPRESSION PROFILING; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MONOCYTES; NF-KAPPA B; PROINSULIN; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; VACCINES, SUBUNIT;

EID: 84923876450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118562     Document Type: Article

References (71)

1. Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986; 314: 1360-1368. PMID: 3517648
2. Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85: 291-297. PMID: 8616883
3. Melendez-Ramirez LY, Richards RJ, Cefalu WT Complications of type 1 diabetes. Endocrinol Metab Clin North Am. 2010; 39: 625-640. doi: 10.1016/j.ecl.2010.05.009 PMID: 20723824
4. Forbes JM, Cooper ME. Mechanisms of Diabetic Complications. Physiological Reviews. 2013; 93: 137-188. doi: 10.1152/physrev.00045.2011 PMID: 23303908
5. Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol. 2013; 13: 566-577. doi: 10.1038/nri3477 PMID: 23827956
6. Mbongue J, Nicholas D, Firek A, Langridge W. The role of dendritic cells in tissue-specific autoimmunity. J Immunol Res. 2014;857143. doi: 10.1155/2014/857143 PMID: 24877157
7. Allen JS, Pang K, Skowera A, Ellis R, Rackham C, Lozanoska-Ochser B, et al. Plasmacytoid Dendritic Cells Are Proportionally Expanded at Diagnosis of Type 1 Diabetes and Enhance Islet Autoantigen Presentation to T-Cells Through Immune Complex Capture. Diabetes. 2009; 58: 138-145. doi: 10.2337/ db08-0964 PMID: 18835928
8. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994; 331: 1428-1436. PMID: 7969282
9. Han B, Serra P, Yamanouchi J, Amrani A, Elliott JF, Dickie P, et al. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest. 2005; 115: 1879-1887. PMID: 15937548
10. Tang Q, Adams JY, Tooley AJ, Bi M, Fife BT, Serra P, et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol. 2006; 7: 83-92. PMID: 16311599
11. Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A. 1999; 96: 1036-1041. PMID: 9927689
12. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol. 2001; 167: 5067-5076. PMID: 11673516
13. Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity. 2003; 19: 47-57. PMID: 12871638
14. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, et al. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc Natl Acad Sci U S A. 1997; 94: 4610-4614. PMID: 9114038
15. Aspord C, Thivolet C. Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol. 2002; 130: 204-211. PMID: 12390307
16. Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C. Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells. Diabetes. 1999; 48: 2150-2156. PMID: 10535448
17. Odumosu O, Nicholas D, Yano H, LangridgeW(2010) AB toxins: a paradigm switch from deadly to desirable. Toxins (Basel) 2: 1612-1645. doi: 10.3390/toxins2071612 PMID: 22069653
18. Denes B, Krausova V, Fodor N, Timiryasova T, Henderson D, Hough J, et al. Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens. J Immunother. 2005; 28: 438-448. PMID: 16113600
19. Meng Q, Wang W, Shi X, Jin Y, Zhang Y. Protection against autoimmune diabetes by silkwormproduced GFP-tagged CTB-insulin fusion protein. Clin Dev Immunol. 2011; 831704.
20. Denes B, Fodor I, Langridge WH. Persistent suppression of type 1 diabetes by a multicomponent vaccine containing a cholera toxin B subunit-autoantigen fusion protein and complete Freund's adjuvant. Clin Dev Immunol. 2013;578786. doi: 10.1155/2013/578786 PMID: 24319466
21. Denes B, Yu J, Fodor N, Takatsy Z, Fodor I, Langridge WH. Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses. Mol Biotechnol. 2006; 34: 317-327. PMID: 17284779
22. Ruhlman T, Ahangari R, Devine A, Samsam M, Daniell H. Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts-oral administration protects against development of insulitis in non-obese diabetic mice. Plant Biotechnol J. 2007; 5: 495-510. PMID: 17490448
23. Odumosu O, Payne K, Baez I, Jutzy J, Wall N, Langridge W. Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit. Immunobiology. 2011; 216: 447-456. doi: 10.1016/j.imbio.2010.09.008 PMID: 20956025
24. Odumosu O, Nicholas D, Payne K, Langridge W. Cholera toxin B subunit linked to glutamic acid decarboxylase suppresses dendritic cell maturation and function. Vaccine. 2011; 29: 8451-8458. doi: 10. 1016/j.vaccine.2011.07.077 PMID: 21807047
25. Phipps PA, Stanford MR, Sun JB, Xiao BG, Holmgren J, Shinnick T, et al. Prevention of mucosally induced uveitis with a HSP60-derived peptide linked to cholera toxin B subunit. Eur J Immunol. 2003; 33: 224-232. PMID: 12594851
26. Stanford M, Whittall T, Bergmeier LA, Lindblad M, Lundin S, Shinnick T, et al. Oral tolerization with peptide 336- 351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol. 2004; 137: 201-208. PMID: 15196263
27. Sun JB, Czerkinsky C, Holmgren J. B Lymphocytes Treated In Vitro with Antigen Coupled to Cholera Toxin B Subunit Induce Antigen-Specific Foxp3(+) Regulatory T Cells and Protect against Experimental Autoimmune Encephalomyelitis. Journal of Immunology. 2012; 188: 1686-1697. doi: 10.4049/ jimmunol.1101771 PMID: 22250081
28. Arakawa T, Chong DK, Langridge WH Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat Biotechnol. 1998; 16: 292-297. PMID: 9528012
29. Carter JE 3rd, Yu J, Choi NW, Hough J, Henderson D, He D, et al. Bacterial and plant enterotoxin B subunit-autoantigen fusion proteins suppress diabetes insulitis. Mol Biotechnol. 2006; 32: 1-15. PMID: 16382177
30. Umezawa K. Inhibition of tumor growth by NF-kappaB inhibitors. Cancer Sci. 2006; 97: 990-995. PMID: 16925581
31. Sanda T, Iida S, Ogura H, Asamitsu K, Murata T, Bacon KB, et al. Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor. Clin Cancer Res. 2005; 11: 1974-1982. PMID: 15756023
32. Salahshoor MR, Dastjerdi MN, Jalili C, Mardani M, Khazaei M, Darehdor AS, et al. Combination of Salermide and Cholera Toxin B Induce Apoptosis in MCF-7 but Not in MRC-5 Cell Lines. Int J Prev Med. 2013; 4: 1402-1413. PMID: 24498496
33. Takikawa O, Kuroiwa T, Yamazaki F, Kido R Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem. 1988; 263: 2041-2048. PMID: 3123485
34. Belladonna ML, Puccetti P, Orabona C, Fallarino F, Vacca C, Volpi C, et al. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. Transplantation. 2007; 84: S17-20. doi: 10.1097/01.tp.0000296019.85986.af PMID: 18162980
35. Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cell subsets. Immunity. 2010; 33: 464-478. doi: 10.1016/j.immuni.2010.10.007 PMID: 21029958
36. Faure-Andre G, Vargas P, Yuseff MI, Heuze M, Diaz J, Lankar D, et al. Regulation of dendritic cell migration by CD74, the MHC class II-associated invariant chain. Science. 2008; 322: 1705-1710. doi: 10. 1126/science.1159894 PMID: 19074353
37. Woltman AM, van Kooten C. Functional modulation of dendritic cells to suppress adaptive immune responses. J Leukoc Biol. 2003; 73: 428-441. PMID: 12660217
38. Sick E, Jeanne A, Schneider C, Dedieu S, Takeda K, Martiny L. CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest. Br J Pharmacol. 2012; 167: 1415-1430. doi: 10.1111/j.1476-5381.2012.02099.x PMID: 22774848
39. Van VQ, Lesage S, Bouguermouh S, Gautier P, Rubio M, Levesque M, et al. Expression of the selfmarker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs. EMBO J. 2006; 25: 5560-5568. PMID: 17093498
40. Matozaki T, Murata Y, Okazawa H, Ohnishi H Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol. 2009; 19: 72-80. doi: 10.1016/j.tcb.2008.12.001 PMID: 19144521
41. Tas SW, Vervoordeldonk MJ, Hajji N, Schuitemaker JH, van der Sluijs KF, May MJ, et al. Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood. 2007; 110: 1540-1549. PMID: 17483297
42. Muller AJ, DuHadaway JB, Donover PS, Sutanto-Ward E, Prendergast GC. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat Med. 2005; 11: 312-319. PMID: 15711557
43. Grohmann U, Fallarino F, Bianchi R, Orabona C, Vacca C, Fioretti MC, et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med. 2003; 198: 153-160. PMID: 12835483
44. Orabona C, Puccetti P, Vacca C, Bicciato S, Luchini A, Fallarino F, et al. Toward the identification of a tolerogenic signature in IDO-competent dendritic cells. Blood. 2006; 107: 2846-2854. PMID: 16339401
45. Caux C, Liu YJ, Banchereau J Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol Today. 1995; 16: 2-4. PMID: 7880384
46. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol. 1997; 27: 431-441. PMID: 9045914
47. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, et al. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010; 116: e74-80. doi: 10.1182/blood-2010-02-258558 PMID: 20628149
48. Najfeld V, Menninger J, Muhleman D, Comings DE, Gupta SL. Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12->p11 by fluorescent in situ hybridization. Cytogenet Cell Genet. 1993; 64: 231-232. PMID: 8404046
49. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol. 2006; 176: 6752-6761. PMID: 16709834
50. Harden JL, Egilmez NK Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest. 2012; 41: 738-764. doi: 10.3109/08820139.2012.676122 PMID: 23017144
51. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. 2002; 196: 459-468. PMID: 12186838
52. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood. 2009; 114: 5062-5070. doi: 10.1182/blood-2009-06-227587 PMID: 19828695
53. Zaher SS, Germain C, Fu H, Larkin DF, George AJ. 3-hydroxykynurenine suppresses CD4+ T-cell proliferation, induces T-regulatory-cell development, and prolongs corneal allograft survival. Invest Ophthalmol Vis Sci. 2011; 52: 2640-2648. doi: 10.1167/iovs.10-5793 PMID: 21212175
54. Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H, et al. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol. 2010; 185: 5953-5961. doi: 10.4049/jimmunol.1001628 PMID: 20944000
55. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010; 185: 3190-3198. doi: 10.4049/jimmunol.0903670 PMID: 20720200
56. Pallotta MT, Orabona C, Bianchi R, Vacca C, Fallarino F, Belladonna ML, et al. Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes. J Cell Mol Med. 2014; 18: 2082-2091. doi: 10.1111/jcmm.12360 PMID: 25215657
57. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011; 12: 870-878. doi: 10.1038/ni.2077 PMID: 21804557
58. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med. 2002; 196: 447-457. PMID: 12186837
59. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 2002; 9: 1069-1077. PMID: 12232795
60. Slavica L, Nurkkala-Karlsson M, Karlson T, Ingelsten M, Nystrom J, Eriksson K. Indoleamine 2,3-dioxygenase Expression and Functional Activity in Dendritic Cells Exposed to Cholera Toxin. Scandinavian Journal of Immunology. 2012; 76: 113-122. doi: 10.1111/j.1365-3083.2012.02713.x PMID: 22519828
61. Nguyen NT, Kimura A, Nakahama T, Chinen I, Masuda K, Nohara K, et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci U S A. 2010; 107: 19961-19966. doi: 10.1073/pnas.1014465107 PMID: 21041655
62. Vogel CFA, Wu DL, Goth SR, Baek J, Lollies A, Domhardt R, et al. Aryl hydrocarbon receptor signaling regulates NF-kappa B RelB activation during dendritic-cell differentiation. Immunology and Cell Biology. 2013; 91: 568-575. doi: 10.1038/icb.2013.43 PMID: 23999131
63. Prado C, Contreras F, Gonzalez H, Diaz P, Elgueta D, Barrientos M, et al. Stimulation of dopamine receptor D5 expressed on dendritic cells potentiates Th17-mediated immunity. J Immunol. 2012; 188: 3062-3070. doi: 10.4049/jimmunol.1103096 PMID: 22379034
64. Dilioglou S, Cruse JM, Lewis RE. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Exp Mol Pathol. 2003; 75: 217-227. PMID: 14611813
65. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature. 1998; 391: 703-707. PMID: 9490415
66. Schmidt NW, Thieu VT, Mann BA, Ahyi AN, Kaplan MH. Bruton's tyrosine kinase is required for TLRinduced IL-10 production. J Immunol. 2006; 177: 7203-7210. PMID: 17082638
67. Relloso M, Puig-Kroger A, Pello OM, Rodriguez-Fernandez JL, de la Rosa G, Longo N, et al. DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and antiinflammatory agents. J Immunol. 2002; 168: 2634-2643. PMID: 11884427
68. Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol. 2000; 104: 10-15. PMID: 11111115
69. Chang TT, Kuchroo VK, Sharpe AH. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Curr Dir Autoimmun. 2002; 5: 113-130. PMID: 11826754
70. Wellcome Trust Case Control C Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-678. PMID: 17554300
71. Carrero JA, Calderon B, Towfic F, Artyomov MN, Unanue ER. Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS One 2013; 8: e59701. doi: 10.1371/journal. pone.0059701 PMID: 23555752